{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:21:37Z","timestamp":1761895297385,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.lfs.2011.06.019","type":"journal-article","created":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T09:47:54Z","timestamp":1310118474000},"page":"269-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Repeated enemas with hepatocyte growth factor selectively stimulate epithelial cell proliferation of injured mucosa in rats with experimental colitis"],"prefix":"10.1016","volume":"89","author":[{"given":"Hitoshi","family":"Setoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Ido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Numata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Funakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Sakiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Uto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Oketani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Tsubouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2011.06.019_bb0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ajg.2010.428","article-title":"The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case\u2013control study","volume":"106","author":"Baars","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lfs.2011.06.019_bb0010","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1572-0241.2006.00524.x","article-title":"Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease\u2014a long-term follow-up","volume":"101","author":"Baumgart","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lfs.2011.06.019_bb0015","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoploriferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancer"},{"key":"10.1016\/j.lfs.2011.06.019_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2011.06.019_bb0025","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lfs.2011.06.019_bb0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/gast.2002.30328","article-title":"Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine","volume":"122","author":"Dayharsh","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2011.06.019_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000089781","article-title":"Inflammatory bowel disease: current therapeutic options","volume":"73","author":"Domenech","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.lfs.2011.06.019_bb0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/gast.2001.26279","article-title":"The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study","volume":"121","author":"Faubion","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2011.06.019_bb0045","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI113334","article-title":"Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure","volume":"81","author":"Gohda","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lfs.2011.06.019_bb0050","first-page":"81","article-title":"The state of the art in the management of inflammatory bowel disease","volume":"3","author":"Hanauer","year":"2003","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.lfs.2011.06.019_bb0055","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/j.1440-1746.2005.03922.x","article-title":"Hepatocyte growth factor accelerates the proliferation of hepatic oval cells in a 2-acetylaminofluorene\/partial hepatectomy model in rats","volume":"20","author":"Hasuike","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.lfs.2011.06.019_bb0060","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1872-034X.2009.00542.x","article-title":"Translational research to identify clinical applications of hepatocyte growth factor","volume":"39","author":"Ido","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1016\/j.lfs.2011.06.019_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.hepres.2004.09.002","article-title":"Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein","volume":"30","author":"Ido","year":"2004","journal-title":"Hepatol Res"},{"key":"10.1016\/j.lfs.2011.06.019_bb0070","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1152\/ajpgi.2000.278.4.G635","article-title":"Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa","volume":"278","author":"Itoh","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.lfs.2011.06.019_bb0075","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1172\/JCI115992","article-title":"Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor","volume":"90","author":"Joplin","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lfs.2011.06.019_bb0080","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2011.06.019_bb0085","doi-asserted-by":"crossref","first-page":"40453","DOI":"10.1074\/jbc.M006412200","article-title":"Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment","volume":"275","author":"Kataoka","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2011.06.019_bb0090","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1073\/pnas.91.10.4357","article-title":"Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice","volume":"91","author":"Kawaida","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lfs.2011.06.019_bb0095","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/PL00000212","article-title":"Expression of hepatocyte growth factor and c-met in ulcerative colitis","volume":"49","author":"Kitamura","year":"2000","journal-title":"Inflamm Res"},{"key":"10.1016\/j.lfs.2011.06.019_bb0100","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1159\/000320276","article-title":"Inflammatory bowel disease as a risk factor for colorectal cancer","volume":"28","author":"Lukas","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.lfs.2011.06.019_bb0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000198104","article-title":"Experimental production of diffuse colitis in rats","volume":"17","author":"Macpherson","year":"1978","journal-title":"Digestion"},{"key":"10.1016\/j.lfs.2011.06.019_bb0110","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1161\/01.CIR.0000016722.37138.F2","article-title":"Myocardial regeneration therapy for heart failure: hepatycte growth factor enhances the effect of cellular cardiomyoplasty","volume":"105","author":"Miyagawa","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2011.06.019_bb0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11894-006-0040-6","article-title":"Insights in immunomodulatory therapies for ulcerative colitis and Crohn's disease","volume":"8","author":"Nguyen","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.lfs.2011.06.019_bb0120","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.MIB.0000164192.71381.5c","article-title":"Hepatocyte growth factor facilitates the repair of large colonic ulcers in 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats","volume":"11","author":"Numata","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.lfs.2011.06.019_bb0125","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1172\/JCI117200","volume":"93","author":"Nusrat","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lfs.2011.06.019_bb0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00054725-200002000-00009","article-title":"How to do without steroids in inflammatory bowel disease","volume":"6","author":"Present","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.lfs.2011.06.019_bb0135","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1046\/j.1365-2036.2001.01060.x","article-title":"Review article: the limitations of corticosteroid therapy in Crohn's disease","volume":"15","author":"Rutgeerts","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lfs.2011.06.019_bb0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00054725-199905000-00008","article-title":"Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety","volume":"5","author":"Sandborn","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.lfs.2011.06.019_bb0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2036.2010.04489.x","article-title":"Review article: explaining risks of inflammatory bowel disease therapy to patients","volume":"33","author":"Siegel","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lfs.2011.06.019_bb0150","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cgh.2009.01.004","article-title":"Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis","volume":"7","author":"Siegel","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lfs.2011.06.019_bb0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(24)29668-3","article-title":"Adnosine kinase inhibitor GP515 improves experimental colitis in mice","volume":"296","author":"Siegmund","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2011.06.019_bb0160","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1523\/JNEUROSCI.22-15-06537.2002","article-title":"Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS","volume":"22","author":"Sun","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.lfs.2011.06.019_bb0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.103.054106","article-title":"Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats","volume":"307","author":"Tahara","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2011.06.019_bb0170","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1006\/bbrc.1993.1250","article-title":"Hepatocyte growth factor induces mitogenic reaction to the rabbit gastric epithelial cells in primary culture","volume":"191","author":"Takahashi","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lfs.2011.06.019_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840130102","article-title":"Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay","volume":"13","author":"Tsubouchi","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2011.06.019_bb0180","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0016-5085(03)01067-9","article-title":"Dietary glycine prevents chemical-induced experimental colitis in the rats","volume":"125","author":"Tsune","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2011.06.019_bb0185","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1164\/ajrccm.156.6.9611057","article-title":"Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphogenic study","volume":"156","author":"Yaekawa","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lfs.2011.06.019_bb0190","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00005344-199709000-00004","article-title":"Hemodynamic effects of scatter factor in conscious rats","volume":"30","author":"Yang","year":"1997","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320511003110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320511003110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:10:04Z","timestamp":1758399004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320511003110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":38,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0024320511003110"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2011.06.019","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeated enemas with hepatocyte growth factor selectively stimulate epithelial cell proliferation of injured mucosa in rats with experimental colitis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2011.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}